HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NK 252

potentiates the action of antitumor drugs against drug-sensitive tumors; structure given in first source
Also Known As:
NK-252
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Wang, Rupeng: 1 article (01/2021)
2. Xu, Guiyu: 1 article (01/2021)
3. Ye, Huiming: 1 article (01/2021)
4. Zhang, Dexian: 1 article (01/2021)
5. Aoki, Takumi: 1 article (07/2013)
6. Asaoka, Yoshiji: 1 article (07/2013)
7. Kaino, Mie: 1 article (07/2013)
8. Mochizuki, Hidenori: 1 article (07/2013)
9. Noda, Hidetoshi: 1 article (07/2013)
10. Shimozono, Rieko: 1 article (07/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Leukemia
3. Hypertrophy
4. Fibrosis (Cirrhosis)

Related Drugs and Biologics

1. Vindesine (Vindesin)
2. Vincristine (Oncovin)
3. Vinblastine (Vinblastine Sulfate)
4. Dactinomycin (Actinomycin)
5. Antineoplastic Agents (Antineoplastics)
6. NK 250
7. 1,4-dihydropyridine (dihydropyridine)
8. CDAA (Randox)